Hattersheim, Germany

Yuri Ivashchenko

This inventor holds 4 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Sanofi, Aventis Pharmaceuticals Inc., Sanofi-A Ventis Deutschland Gmbh. Active years: 2010-2014.

USPTO Granted Patents = 4 

% Patents Active = 25.0

 

Average Co-Inventor Count = 5.2

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2010-2014

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Inventor Yuri Ivashchenko

Introduction

Yuri Ivashchenko is a notable inventor based in Hattersheim, Germany, who has made significant contributions to the field of pharmaceuticals. With four patents to his name, he has demonstrated a commitment to advancing medical treatments through innovative chemical compounds.

Latest Patents

Among his latest innovations, Yuri Ivashchenko has developed isoquinoline derivatives, specifically 6-piperidinyl-substituted isoquinoline derivatives. These compounds, described by the formula (I), are noteworthy for their potential in the treatment and prevention of diseases associated with Rho-kinase and Rho-kinase mediated phosphorylation of myosin light chain phosphatase. The applications of these derivatives aim to enhance therapeutic outcomes and offer new avenues for disease management.

Career Highlights

Throughout his career, Yuri has collaborated with prominent companies, including Sanofi and Sanofi-Aventis Deutschland GmbH, where he has applied his inventive skills to create impactful pharmaceuticals. His work in these organizations has positioned him at the forefront of medical research and innovation.

Collaborations

During his professional journey, Yuri Ivashchenko has worked alongside distinguished colleagues such as Matthias Loehn and Oliver Plettenburg. These collaborations have contributed to a rich environment of innovation and have aided in the successful development of his patented technologies.

Conclusion

Yuri Ivashchenko's contributions to the field of pharmaceuticals, particularly with his innovative isoquinoline derivatives, highlight the importance of inventors in advancing medical science. His work continues to inspire future innovations aimed at improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…